Back to search
Hospital-acquired Bacterial Pneumonia (HABP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hospital-acquired Bacterial Pneumonia (HABP) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hospital-acquired Bacterial Pneumonia (HABP) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a two-part study, with Part A being the randomized, controlled portion of the study in patients with hospital-acquired bacterial pneumonia (HABP) or ven…
This is a phase 2a, multinational, multicenter, double-blind, randomized, placebo-controlled, dose-ranging safety, tolerability and PK study in patients with HA…
This study is to evaluate the efficacy and safety of Meropenem and Pralurbactam for Injection in Subjects with HABP/VABP. The primary objective is to demonstrat…
The study will evaluate the efficacy and safety of Meropenem and Pralurbactam versus Best Available Therapy in the treatment of Carbapenem-Resistant Enterobacte…
The purpose of this study is to evaluate the efficacy and safety of HRS -8427 in patients with HABP/VABP.
To evaluate the all-cause mortality rate at Day 28 in the YK-1169 group versus the ceftazidime-avibatan injection group in the mITT population.
The primary purpose of this study is to understand the pharmacokinetics (PK) of single and multiple doses of cefiderocol in children from birth to less than 3 m…